id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-D-5570-0001,FDA,FDA-2017-D-5570,Select Updates for Recommendations for Clinical Laboratory  Improvement Amendments of 1988 Waiver Applications for  Manufacturers of In Vitro Diagnostic Devices; Draft Guidance for Industry and Food and Drug Administration Staff; Availability,Notice,Notice of Availability,2017-11-29T05:00:00Z,2017,11,2017-11-29T05:00:00Z,2018-01-30T04:59:59Z,2018-01-14T03:27:08Z,2017-25775,0,0,0900006482cbbc77
FDA-2017-D-5570-0002,FDA,FDA-2017-D-5570,Select Updates for Recommendations for Clinical Laboratory  Improvement Amendments of 1988 (CLIA) Waiver Applications for Manufacturers of In Vitro Diagnostic Devices Draft Guidance for Industry and Food and Drug Administration Staff,Other,Guidance,2017-11-29T05:00:00Z,2017,11,2017-11-29T05:00:00Z,2018-03-31T03:59:59Z,2024-11-07T01:12:28Z,,1,0,0900006482cbce4e